The story of copyright's flagship drug presents a interesting case for observers in the drug sector. While initially a phenomenal success, generating vast sums, the exclusivity end and the subsequent flood of off-brand https://adult272050.affiliatblogger.com/94206798/sildenafil-and-the-pharmaceutical-industry-a-risky-bet